Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Black Diamond Therapeutic Q1 Earnings

Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Black Diamond Therapeutic beat estimated earnings by 6.56%, reporting an EPS of $-0.57 versus an estimate of $-0.61.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 6.9% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Black Diamond Therapeutic visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

LiveOne Announces Milestone Revenues; $31M+ For Q3 FY 2024 And $87M+ FYTD 2024; Record $80M For The Audio Division For The First 9 months, +25% YoY; Record Q3 Audio Division Revenue of $27M+; Expands Partnership With Telsa To include Truck Division

By Benzinga Newsdesk
January 16, 1:32 PM
- $31M+ for 3Q FY 2024 and $87M+ FYTD 2024- Record $80M for the Audio Division for the first 9 months  (+25% YOY)- Record Q3 Audio Division Revenue of $27M+- Expands Partnership with Telsa to include Truck Division-

LVO